Published in World J Gastroenterol on September 28, 2010
The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol (2011) 1.27
Mycobacterium avium subspecies paratuberculosis causes Crohn's disease in some inflammatory bowel disease patients. World J Gastroenterol (2014) 0.99
Crohn's disease and Mycobacterium avium subsp. paratuberculosis: the need for a study is long overdue. Vet Immunol Immunopathol (2011) 0.95
Experimental infection of a bovine model with human isolates of Mycobacterium avium subsp. paratuberculosis. Vet Immunol Immunopathol (2011) 0.94
Pathogenesis of Crohn's disease: Bug or no bug. World J Gastrointest Pathophysiol (2015) 0.84
Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn's disease, cause or epiphenomenon? World J Gastroenterol (2014) 0.83
On deaf ears, Mycobacterium avium paratuberculosis in pathogenesis Crohn's and other diseases. World J Gastroenterol (2015) 0.81
Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis. BMC Gastroenterol (2011) 0.81
Lactase persistence, NOD2 status and Mycobacterium avium subsp. paratuberculosis infection associations to Inflammatory Bowel Disease. Gut Pathog (2012) 0.79
Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis. World J Gastroenterol (2015) 0.79
M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity. Autoimmune Dis (2012) 0.79
Detection of Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease is unrelated to the presence of single nucleotide polymorphisms rs2241880 (ATG16L1) and rs10045431 (IL12B). Med Microbiol Immunol (2014) 0.78
Assessment of the microbiota in microdissected tissues of Crohn's disease patients. Int J Inflam (2011) 0.78
Concurrent Resolution of Chronic Diarrhea Likely Due to Crohn's Disease and Infection with Mycobacterium avium paratuberculosis. Front Med (Lausanne) (2016) 0.77
Increased viability but decreased culturability of Mycobacterium avium subsp. paratuberculosis in macrophages from inflammatory bowel disease patients under Infliximab treatment. Med Microbiol Immunol (2015) 0.77
The Features of Fecal and Ileal Mucosa-Associated Microbiota in Dairy Calves during Early Infection with Mycobacterium avium Subspecies paratuberculosis. Front Microbiol (2016) 0.76
Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease. World J Gastroenterol (2014) 0.75
Development of a Recombinase Polymerase Amplification Assay for Rapid Detection of the Mycobacterium avium subsp. paratuberculosis. PLoS One (2016) 0.75
Mycobacterium paratuberculosis as a cause of Crohn's disease. Expert Rev Gastroenterol Hepatol (2015) 0.75
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet (2006) 15.14
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet (2007) 13.74
Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell (2004) 12.71
Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl (1989) 9.56
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27
Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet (2004) 6.84
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology (2007) 5.40
Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis (2003) 3.42
Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol (2003) 3.09
Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis (2007) 2.85
Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J Clin Microbiol (1986) 2.55
Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis (2008) 2.12
Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol (2004) 1.98
Integrating theories of the etiology of Crohn's disease. On the etiology of Crohn's disease: questioning the hypotheses. Med Sci Monit (2006) 1.74
Mycobacterium paratuberculosis infection in a colony of stumptail macaques (Macaca arctoides). J Infect Dis (1987) 1.70
Identification of spheroplast-like agents isolated from tissues of patients with Crohn's disease and control tissues by polymerase chain reaction. J Clin Microbiol (1993) 1.52
Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut (2005) 1.51
Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine. Ann Med (2007) 1.29
Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J Leukoc Biol (2007) 1.22
Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease. World J Gastroenterol (2009) 1.06
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro. Antimicrob Agents Chemother (2007) 1.00
IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis (2008) 0.93
Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease. Scand J Gastroenterol (2003) 0.93
Absence of Mycobacterium avium subspecies paratuberculosis in Crohn's disease patients. Inflamm Bowel Dis (2006) 0.82
Lack of evidence for Mycobacterium avium subspecies paratuberculosis in Crohn's disease. Inflamm Bowel Dis (2005) 0.81
CCFA microbial-host interactions workshop: highlights and key observations. Inflamm Bowel Dis (2007) 0.81
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet (2011) 6.36
Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease. Gastroenterology (2013) 4.11
[Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis]. Med Clin (Barc) (2005) 2.90
Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis (2010) 2.02
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis (2009) 1.68
In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob Agents Chemother (2002) 1.65
MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis (2006) 1.54
Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy. Eur J Intern Med (2011) 1.48
TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis. Neurology (2013) 1.47
Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines. Am J Gastroenterol (2010) 1.47
Translation, cultural adaptation and validation of a Spanish version of the Irritable Bowel Syndrome Severity Score. Rev Esp Enferm Dig (2011) 1.38
Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat Genet (2010) 1.32
In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci. J Antimicrob Chemother (2011) 1.24
Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci (2002) 1.21
Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol (2003) 1.20
Identification of Acinetobacter species: is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques? Infect Genet Evol (2012) 1.19
The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases. Ann Rheum Dis (2009) 1.17
Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin. Clin Mol Allergy (2005) 1.15
Comparative activity of carbapenem testing: the COMPACT study. J Antimicrob Chemother (2011) 1.11
Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob Agents Chemother (2002) 1.10
Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease. PLoS One (2012) 1.09
Update on pathogenesis and clinical management of acute pancreatitis. World J Gastrointest Pathophysiol (2012) 1.08
IFIH1-GCA-KCNH7 locus: influence on multiple sclerosis risk. Eur J Hum Genet (2008) 1.08
MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes. J Immunol (2002) 1.06
Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease. World J Gastroenterol (2009) 1.06
Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis (2006) 1.06
Ammonium assimilation and amino acid metabolism in conifers. J Exp Bot (2007) 1.05
Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use. Br J Pharmacol (2004) 1.03
Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics (2006) 1.02
[Significant increase in the colonisation of Staphylococcus aureus among medical students during their hospital practices]. Enferm Infecc Microbiol Clin (2012) 1.01
CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility. PLoS One (2010) 1.01
Optimized method for Acinetobacter species carbapenemase detection and identification by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2013) 1.00
Role of the PXR gene locus in inflammatory bowel diseases. Inflamm Bowel Dis (2007) 1.00
Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux in Spain. Eur J Gastroenterol Hepatol (2006) 0.98
A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes. Immunogenetics (2011) 0.98
Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study. J Allergy Clin Immunol (2006) 0.97
Crohn's disease: a review of current treatment with a focus on biologics. Drugs (2007) 0.96
Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients. Eur J Hum Genet (2009) 0.96
Association of the organic cation transporter OCTN genes with Crohn's disease in the Spanish population. Eur J Hum Genet (2006) 0.96
Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis (2011) 0.96
Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm Bowel Dis (2005) 0.95
Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid. Int J Antimicrob Agents (2003) 0.95
Splitting irritable bowel syndrome: from original Rome to Rome II criteria. Am J Gastroenterol (2004) 0.95
Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002). Diagn Microbiol Infect Dis (2005) 0.95
High-density SNP mapping of the HLA region identifies multiple independent susceptibility loci associated with selective IgA deficiency. PLoS Genet (2012) 0.94
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. Brain (2013) 0.94
Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics (2007) 0.93
IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis (2008) 0.93
Model-Based de-identification of facial images. AMIA Annu Symp Proc (2008) 0.92
Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. Am J Gastroenterol (2009) 0.92
Gender-specific association of the PTPN22 C1858T polymorphism with achalasia. Hum Immunol (2007) 0.92
Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics (2002) 0.92
Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data. J Gastroenterol Hepatol (2012) 0.91
IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab. World J Gastroenterol (2005) 0.90
IBD1 and IBD3 determine location of Crohn's disease in the Spanish population. Inflamm Bowel Dis (2004) 0.90
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases. J Crohns Colitis (2011) 0.90
Large-scale gene expression in bone marrow mesenchymal stem cells: a putative role for COL10A1 in osteoarthritis. Ann Rheum Dis (2010) 0.90
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1. PLoS One (2012) 0.90
Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain. J Neuroimmunol (2010) 0.90
[Antimicrobial treatment of exacerbation in chronic obstructive pulmonary disease: 2007 consensus statement]. Arch Bronconeumol (2008) 0.89
Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins. Int J Antimicrob Agents (2006) 0.89
Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA. Hum Immunol (2007) 0.89
Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis. Clin Immunol (2010) 0.89
Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: a Study in the Spanish population and a meta-analysis. Inflamm Bowel Dis (2009) 0.89
Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB [correction of CLBL] genes. Mult Scler (2011) 0.89
Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study. BMC Med Genet (2006) 0.88
Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis. PLoS One (2013) 0.88
Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding. Pharmacogenet Genomics (2008) 0.88
Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain. Antimicrob Agents Chemother (2010) 0.87
Outbreak of Acinetobacter baumannii producing OXA-66 in a Spanish hospital: epidemiology and study of patient movements. Microb Drug Resist (2010) 0.87